Back to search
FDAFDA · Food and drugs·Recall number D-0048-2025

Triamcinolone Acetonide Cream USP, 0.025%, 1 LB (454 g) per jar, Rx Only, Manufactured By Padagis, Minneapolis, MN 55427. NDC: 45802-0063-05

Published November 27, 2024 · Recall initiated: October 11, 2024

Summary

FDA records drug Class III recall D-0048-2025, published November 27, 2024 and initiated October 11, 2024. Recalling firm: Padagis US LLC; Status: Terminated; Reported quantity: 10,872 jars; Lot: Lot #: 2024154238, 2024174344, Exp. Date 3/31/2026. Class III means the product is not likely to cause adverse health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Subpotent and Superpotent Drug. Out of specification assay results recorded as part of Uniformity of Container test during long-term stability testing.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Padagis US LLC
Distributor
Nationwide in the USA
Lot
Lot #: 2024154238, 2024174344, Exp. Date 3/31/2026
Risk classification
Class III
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Triamcinolone Acetonide Cream USP, 0.025%, 1 LB (454 g) per jar, Rx Only, Manufactured By Padagis, Minneapolis, MN 55427. NDC: 45802-0063-05 recalled?

Yes. FDA published recall D-0048-2025 on November 27, 2024. Reported hazard: Subpotent and Superpotent Drug. Out of specification assay results recorded as part of Uniformity of Container test during long-term stability testing.

What should I do if I have this product?

Voluntary: Firm initiated · Letter